Antimicrobials in pregnancy: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "== Principles == * Use medications only if absolutely necessary * If possible, avoid therapy during the first trimester * Use a safe medication * Use the narrowest spectrum a..." |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 11: | Line 11: | ||
* [[Penicillins]], including [[amoxicillin]], [[ampicillin]] |
* [[Penicillins]], including [[amoxicillin]], [[ampicillin]] |
||
* [[Cephalosporins]], including [[cefaclor]], [[cephalexin]], although they have been associated with [[kernicterus]] ([[ |
* [[Cephalosporins]], including [[cefaclor]], [[cephalexin]], although they have been associated with [[kernicterus]] ([[ceftriaxone]]) |
||
* [[Azithromycin]], which is preferred to [[erythromycin]] and [[clindamycin]] |
* [[Azithromycin]], which is preferred to [[erythromycin]] and [[clindamycin]] |
||
* [[Vancomycin]], [[daptomycin]], [[fidaxomicin]] |
* [[Vancomycin]], [[daptomycin]], [[fidaxomicin]] |
||
| Line 17: | Line 17: | ||
* [[Metronidazole]], though topical should be avoided |
* [[Metronidazole]], though topical should be avoided |
||
* [[Fosfomycin]] |
* [[Fosfomycin]] |
||
Avoid unless benefits outweight risks: |
Avoid unless benefits outweight risks: |
||
| Line 24: | Line 25: | ||
* [[Polymixins]] |
* [[Polymixins]] |
||
* [[Cotrimoxazole]]: avoid in first trimester (congenital malformations), and after 32 weeks (risk of kernicterus); has been associated with [[diaphragmatic hernia]] and [[esophageal atresia]] |
* [[Cotrimoxazole]]: avoid in first trimester (congenital malformations), and after 32 weeks (risk of kernicterus); has been associated with [[diaphragmatic hernia]] and [[esophageal atresia]] |
||
Should be avoided altogether: |
Should be avoided altogether: |
||
| Line 30: | Line 32: | ||
* [[Aminoglycosides]]: streptomycin associated with hearing loss, while others may be used for short courses |
* [[Aminoglycosides]]: streptomycin associated with hearing loss, while others may be used for short courses |
||
* [[Tetracyclines]] can discolor a developing baby's teeth and aren't recommended after the 15th week of pregnancy |
* [[Tetracyclines]] can discolor a developing baby's teeth and aren't recommended after the 15th week of pregnancy |
||
* [[Fluconazole]] is associated with spontaneous abortion |
|||
== Further Reading == |
|||
* A Review of Antibiotic Use in Pregnancy. ''Pharmacotherapy''. 2015;35(11):1052-62. doi: [https://doi.org/10.1002/phar.1649 10.1002/phar.1649] |
|||
[[Category:Antimicrobials]] |
[[Category:Antimicrobials]] |
||
Latest revision as of 13:29, 9 February 2026
Principles
- Use medications only if absolutely necessary
- If possible, avoid therapy during the first trimester
- Use a safe medication
- Use the narrowest spectrum and shortest course
- When possible, use a single agent
Specific Antimicrobials
Generally considered safe in pregnancy:
- Penicillins, including amoxicillin, ampicillin
- Cephalosporins, including cefaclor, cephalexin, although they have been associated with kernicterus (ceftriaxone)
- Azithromycin, which is preferred to erythromycin and clindamycin
- Vancomycin, daptomycin, fidaxomicin
- Nitrofurantoin, although it has been associated with orofacial clefts including cleft lip and cleft palate
- Metronidazole, though topical should be avoided
- Fosfomycin
Avoid unless benefits outweight risks:
- Fluoroquinolones, based on animal data of bone and cartilage damage
- Linezolid
- Polymixins
- Cotrimoxazole: avoid in first trimester (congenital malformations), and after 32 weeks (risk of kernicterus); has been associated with diaphragmatic hernia and esophageal atresia
Should be avoided altogether:
- Tigecycline
- Aminoglycosides: streptomycin associated with hearing loss, while others may be used for short courses
- Tetracyclines can discolor a developing baby's teeth and aren't recommended after the 15th week of pregnancy
- Fluconazole is associated with spontaneous abortion
Further Reading
- A Review of Antibiotic Use in Pregnancy. Pharmacotherapy. 2015;35(11):1052-62. doi: 10.1002/phar.1649